Coq10 vs. Lanoxin: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Coq10 and Lanoxin. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 154,690 people who take Coq10 and Lanoxin, and is updated regularly.
What is Coq10?
Coq10 has active ingredients of coenzyme q - 10. It is often used in high blood cholesterol. eHealthMe is studying from 10,401 Coq10 users. Check the latest studies of Coq10.
What is Lanoxin?
Lanoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 21,852 Lanoxin users. Check the latest studies of Lanoxin.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
154,690 people who take Coq10 and Lanoxin are studied.
Drugs being compared in this study:
- Coq10 (coenzyme q - 10)
- Lanoxin (digoxin)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Coq10:
- not at all: 4.25 %
- somewhat: 20.89 %
- moderate: 37.62 %
- high: 31.05 %
- very high: 6.19 %
Lanoxin:
- not at all: 4.38 %
- somewhat: 17.76 %
- moderate: 34.23 %
- high: 30.37 %
- very high: 13.26 %
Want to compare Coq10 with Lanoxin?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
- Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W, "A randomized controlled trial of coenzyme Q 10 for fatigue in the late-onset sequelae of poliomyelitis", Complementary therapies in medicine, 2015 Dec .
- Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .
- Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
- Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W, "A randomized controlled trial of coenzyme Q 10 for fatigue in the late-onset sequelae of poliomyelitis", Complementary therapies in medicine, 2015 Dec .
- Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .
Related studies
Alternative drugs to, pros and cons of:
Browse all side effects of Coq10:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Lanoxin:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on coenzyme q - 10 and digoxin (the active ingredients of Coq10 and Lanoxin, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Renvela and Fish Oil - 3 seconds ago
- Could Navelbine cause Weakness? - 5 seconds ago
- Could Navelbine cause Haemorrhoids? - 6 seconds ago
- Could Navelbine cause Pelvi-Ureteric Obstruction? - 9 seconds ago
- Could Lisinopril cause Cervicitis? - 11 seconds ago
- Could Cytarabine cause Procedural Complication? - 12 seconds ago
- Could Cymbalta cause Muscle Contractions Involuntary? - 13 seconds ago
- Could Artane cause Enlarged Heart? - 14 seconds ago
- Could Docetaxel cause Hypotonia? - 22 seconds ago
- Could Glucosamine cause Insomnia Exacerbated? - 22 seconds ago